
RxSight (RXST) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 3, 2026 | $-0.21 | $-0.23 | 8.70 % |
| Q2 | Aug 5, 2026 | $-0.11 | $-0.23 | 52.2 % |
| Q1 | May 6, 2026 | $-0.19 | $-0.16 | -18.8 % |
| Q4 | Feb 25, 2026 | $-0.03 | $-0.28 | 89.3 % |
Quarterly Revenue (Billions)
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 3, 2026 | $24.59M | $27.25M | -9.79 % |
| Q2 | Aug 5, 2026 | $33.74M | $32.07M | 5.23 % |
| Q1 | May 6, 2026 | $30.89M | $29.74M | 3.88 % |
| Q4 | Feb 25, 2026 | $32.61M | $32.60M | 0.02 % |
RxSight (RXST) last issued guidance on July 6, 2026 for fiscal year 2026. The company guided revenue in the range of $140M - $160M for the period.
Compared to prior guidance, RxSight raised its revenue forecast from a prior range of $120M - $135M.
RxSight has issued 30 guidance updates between January 8, 2023 and July 6, 2026. During this period, the company raised its outlook 14 times and lowered it 8 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.23 | $-0.23 | $-0.16 | $-0.28 |
| Actual | $-0.21 | $-0.11 | $-0.19 | $-0.03 |
| Surprise | +8.70% | +52.2% | -18.8% | +89.3% |
| Revenue | ||||
| Estimate | $27.3M | $32.1M | $29.7M | $32.6M |
| Actual | $24.6M | $33.7M | $30.9M | $32.6M |
| Surprise | -9.79% | +5.23% | +3.88% | +0.02% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.32 | $-0.17 | $-0.30 | $-0.28 |
| Revenue | ||||
| Consensus | $57.6M | $30.2M | — | — |